> ## Content Index > Fetch the complete content index at: https://www.thepsychedelicblog.com/llms.txt > Use this file to discover other available public pages before exploring further. # The Psychedelic Morning Brief - URL: https://www.thepsychedelicblog.com/the-psychedelic-morning-brief-2/ - Published: 2026-09-07T11:19:46.000Z - Updated: 2026-09-07T11:19:46.000Z - Author: Andrew M Weisse ## 💰 **Musk’s Inner Circle Is Betting Big on Psychedelics** **Synopsis:** 2 longtime Elon Musk allies & SpaceX directors, Antonio Gracias & Steve Jurvetson, are putting millions behind efforts to move Psychedelics into mainstream medicine. Gracias’s family foundation reportedly invested $25 million to rescue the company formerly known as Lykos Therapeutics, while Jurvetson has funded Psychedelic research. **My take:** Psychedelics entering the mainstream was always going to require serious capital, and serious capital comes with people many in this community won’t like. That’s not necessarily a bad thing. If the science is good & the treatments work, I care far more about whether millions of people gain access than whether the investors pass someone’s ideological purity test. [https://www.wsj.com/health/healthcare/elon-musks-inner-circle-is-pouring-cash-into-making-psychedelics-mainstream-98ea1b57](https://www.wsj.com/health/healthcare/elon-musks-inner-circle-is-pouring-cash-into-making-psychedelics-mainstream-98ea1b57?ref=thepsychedelicblog.com) ## 🇳🇿 **New Zealand Approves MDMA for Severe PTSD** **Synopsis:** New Zealand has authorized 2 psychiatrists to prescribe pharmaceutical-grade MDMA to adults with severe PTSD, becoming the second country after Australia to permit its clinical use for PTSD. **My take:** Australia’s rollout was plagued by problems (only \~200 people have received treatment). Hopefully NZ can learn from their mistakes. ## 🍄 **Psilocybin Shows Promise for Anxiety** **Synopsis:** A new review in *Neuropsychopharmacology* argues that Psilocybin is emerging as a potentially distinct treatment for anxiety. The authors point to converging preclinical, neuroimaging & clinical evidence, including trials in patients with life-threatening cancer where a single high-dose session produced substantial and sustained reductions in anxiety. **My take:** This is where Psychedelic research needs to remain disciplined. “Promising” & “proven” are not synonyms. The early anxiety data are compelling, but much of the strongest evidence comes from people facing life-threatening illness.